Reviva Pharmaceuticals Hldg Inc
(RVPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 11-2020 | 09-2020 | 08-2020 | 06-2020 | 05-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 37 | N/A | 16 | N/A | 198 |
| TOTAL | $44 | $N/A | $38 | $N/A | $240 |
| Non-Current Assets | |||||
| Investments And Advances | 34,650 | 0 | 34,440 | 0 | 34,219 |
| TOTAL | $34,650 | $N/A | $34,440 | $N/A | $34,219 |
| Total Assets | $34,694 | $N/A | $34,478 | $N/A | $34,459 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 860 | 0 | 736 | 0 | 501 |
| TOTAL | $860 | $N/A | $736 | $N/A | $501 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 28,834 | 0 | 28,742 | 0 | 28,958 |
| TOTAL | $28,834 | $N/A | $28,742 | $N/A | $28,958 |
| Total Liabilities | $29,694 | $N/A | $29,478 | $N/A | $29,459 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,232 | N/A | 5,124 | N/A | 5,135 |
| Common Shares | 4,828 | N/A | 4,480 | N/A | 3,964 |
| Retained earnings | 172 | N/A | 520 | N/A | 1,036 |
| TOTAL | $5,000 | $N/A | $5,000 | $N/A | $5,000 |
| Total Liabilities And Equity | $34,694 | $0 | $34,478 | $0 | $34,459 |